Skip to content

MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease

MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05264051
Enrollment
1200
Registered
2022-03-03
Start date
2022-04-18
Completion date
2027-03-01
Last updated
2026-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Diseases

Brief summary

The purpose of the study is to study the muscle assessment score (MAsS, utilizing MRI, as an objective measure of frailty and muscle composition to serve as a predictor of morbidity and mortality in patients with liver disease.

Detailed description

Prospective study of patients seen at the Univ. of Chicago Medical Center hospital and ambulatory clinics. The assessment of the MAsS score will require an additional 8-10 minutes in the MRI for each patient already undergoing MRI exam. Four groups of pts. who are already scheduled for MRI for routine clinical purposes will be evaluated. 1. Pts. hospitalized with acute hepatic decompensation for whom MRI is otherwise indicated for clinical evaluation. 2. Pts. with hepatobiliary neoplasia 3. Pts.undergoing transjugular portosystemic shunt (TIPS) placement 4. Pts. with chronic liver disease undergoing magnetic resonance elastography for routine monitoring

Interventions

None listed

Sponsors

University of Chicago
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who are already scheduled for an MRI for routine clinical purposes will be evaluated

Exclusion criteria

* \<18 yrs. of age

Design outcomes

Primary

MeasureTime frameDescription
Waitlist MortalityMeasured up to 10 years out from enrollmentDeath prior to liver transplant or delisting from enrollment in the study

Countries

United States

Contacts

Primary ContactOmar Jamil, MD
Omar.Jamil@uchospitals.edu847-373-2360
Backup ContactMaria Newsome
mnewsome1@bsd.uchicago.edu773-702-2788

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026